Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
1999 1
2001 3
2002 3
2004 3
2005 4
2006 5
2007 5
2008 1
2009 2
2010 4
2011 1
2012 4
2013 2
2014 3
2015 8
2016 9
2017 8
2018 2
2019 4
2020 8
2021 7
2022 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.
Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC); Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van 't Hof A, Widimsky P, Zahger D. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), et al. Among authors: van t hof a. Eur Heart J. 2012 Oct;33(20):2569-619. doi: 10.1093/eurheartj/ehs215. Epub 2012 Aug 24. Eur Heart J. 2012. PMID: 22922416 Free article. No abstract available.
Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation.
Brouwer J, Nijenhuis VJ, Delewi R, Hermanides RS, Holvoet W, Dubois CLF, Frambach P, De Bruyne B, van Houwelingen GK, Van Der Heyden JAS, Toušek P, van der Kley F, Buysschaert I, Schotborgh CE, Ferdinande B, van der Harst P, Roosen J, Peper J, Thielen FWF, Veenstra L, Chan Pin Yin DRPP, Swaans MJ, Rensing BJWM, van 't Hof AWJ, Timmers L, Kelder JC, Stella PR, Baan J, Ten Berg JM. Brouwer J, et al. Among authors: van t hof awj. N Engl J Med. 2020 Oct 8;383(15):1447-1457. doi: 10.1056/NEJMoa2017815. Epub 2020 Aug 30. N Engl J Med. 2020. PMID: 32865376 Clinical Trial.
BACKGROUND: The effect of single as compared with dual antiplatelet treatment on bleeding and thromboembolic events after transcatheter aortic-valve implantation (TAVI) in patients who do not have an indication for long-term anticoagulation has not been well studied. METHO …
BACKGROUND: The effect of single as compared with dual antiplatelet treatment on bleeding and thromboembolic events after transcatheter aort …
Final benefit of primary percutaneous coronary intervention for ST-elevation myocardial infarction in older patients: long-term results of a randomised trial.
de Boer MJ, Ottervanger JP, Van't Hof AWJ, Hoorntje JCA, Suryapranata H, Zijlstra F; Zwolle Myocardial Infarction Study Group. de Boer MJ, et al. Among authors: van t hof awj. Neth Heart J. 2022 Dec;30(12):567-571. doi: 10.1007/s12471-022-01724-5. Epub 2022 Sep 16. Neth Heart J. 2022. PMID: 36112340 Free PMC article.
BACKGROUND: Although the short-term benefit of primary percutaneous coronary intervention (PCI) in elderly patients with ST-elevation myocardial infarction (STEMI) has been demonstrated, the final long-term survival benefit is as yet unknown. ...METHODS: Patients &g …
BACKGROUND: Although the short-term benefit of primary percutaneous coronary intervention (PCI) in elderly patients with ST-elevation …
Early Invasive Versus Selective Strategy for Non-ST-Segment Elevation Acute Coronary Syndrome: The ICTUS Trial.
Hoedemaker NPG, Damman P, Woudstra P, Hirsch A, Windhausen F, Tijssen JGP, de Winter RJ; ICTUS Investigators. Hoedemaker NPG, et al. J Am Coll Cardiol. 2017 Apr 18;69(15):1883-1893. doi: 10.1016/j.jacc.2017.02.023. J Am Coll Cardiol. 2017. PMID: 28408018 Free article. Clinical Trial.
BACKGROUND: The ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes) trial compared early invasive strategy with a selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) and an elevated cardiac troponin T. …
BACKGROUND: The ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes) trial compared early invasive strategy with a …
Everolimus eluting stent vs first generation drug-eluting stent in primary angioplasty: A pooled patient-level meta-analysis of randomized trials.
De Luca G, Smits P, Hofma SH, Di Lorenzo E, Vlachojannis GJ, Van't Hof AWJ, van Boven AJ, Kedhi E, Stone GW, Suryapranata H; Drug-Eluting Stent in Primary Angioplasty (DESERT 3) cooperation. De Luca G, et al. Among authors: van t hof awj. Int J Cardiol. 2017 Oct 1;244:121-127. doi: 10.1016/j.ijcard.2017.06.022. Epub 2017 Jun 13. Int J Cardiol. 2017. PMID: 28673736 Review.
BACKGROUND: Several concerns have emerged about the higher risk of very late stent thrombosis (ST) with first generation drug-eluting stent (DES) especially among STEMI patients. Newer generation DES has demonstrated to reduce ST at mid-term follow-up. Therefore, the aim o …
BACKGROUND: Several concerns have emerged about the higher risk of very late stent thrombosis (ST) with first generation drug-eluting stent …
No accelerated arterial aging in relatively young women after preeclampsia as compared to normotensive pregnancy.
Janssen EBNJ, Hooijschuur MCE, Lopes van Balen VA, Morina-Shijaku E, Spaan JJ, Mulder EG, Hoeks AP, Reesink KD, van Kuijk SMJ, Van't Hof A, van Bussel BCT, Spaanderman MEA, Ghossein-Doha C. Janssen EBNJ, et al. Among authors: van t hof a. Front Cardiovasc Med. 2022 Jul 28;9:911603. doi: 10.3389/fcvm.2022.911603. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35966519 Free PMC article.
Effect modification by preeclampsia was investigated by including an interaction term between preeclampsia and age in regression models. RESULTS: Of the 1,217 included women (age range 22-62 years), 66.0% had a history of preeclampsia and 34.0% of normotensive pregnancy. . …
Effect modification by preeclampsia was investigated by including an interaction term between preeclampsia and age in regression mode …
Short-term dual antiplatelet therapy in diabetic patients admitted for acute coronary syndrome treated with a new-generation drug-eluting stent.
Vranken NPA, Rasoul S, Luijkx JJP, Pustjens TFS, Postma S, Kolkman EJ, Kedhi E, Rifqi S, Lee MKY, Ebelt H, Merkely B, Verdoia M, Wojakowski W, van 't Hof AAWJ, Suryapranata H, De Luca G. Vranken NPA, et al. Among authors: van t hof aawj. Diabetes Metab Res Rev. 2022 Jul;38(5):e3530. doi: 10.1002/dmrr.3530. Epub 2022 Apr 22. Diabetes Metab Res Rev. 2022. PMID: 35395144 Free PMC article. Clinical Trial.
This is a prespecified sub-study from the Randomised Evaluation of short-term DUal antiplatelet therapy in patients with acute Coronary syndromE treated with a new generation DES (REDUCE) trial that was designed to determine the efficacy and safety of short-term ver …
This is a prespecified sub-study from the Randomised Evaluation of short-term DUal antiplatelet therapy in patients with acute Corona …
Cardiogenic Shock Predicts Long-term Mortality in Hospital Survivors of STEMI Treated With Primary Percutaneous Coronary Intervention.
Hemradj VV, Ottervanger JP, van 't Hof AW, Dambrink JH, Gosselink M, Kedhi E, Suryapranata H; Zwolle Myocardial Infarction Study Group. Hemradj VV, et al. Among authors: van t hof aw. Clin Cardiol. 2016 Nov;39(11):665-669. doi: 10.1002/clc.22580. Epub 2016 Oct 24. Clin Cardiol. 2016. PMID: 27775864 Free PMC article.
After multivariate analysis, CS was still a significant predictor of long-term mortality in hospital survivors (hazard ratio: 2.6, 95% confidence interval: 1.64-4.01). CONCLUSIONS: Cardiogenic shock remains a strong predictor of long-term mortality in hospital survi …
After multivariate analysis, CS was still a significant predictor of long-term mortality in hospital survivors (hazard ratio: 2.6, 95 …
Unraveling the Multitude of Etiologies in Myocardial Infarction With Nonobstructive Coronary Arteries.
Pustjens TFS, Vranken NPA, Hermanides RS, Rasoul S, Ottervanger JP, Van't Hof AWJ. Pustjens TFS, et al. Among authors: van t hof awj. Am J Cardiol. 2022 Apr 1;168:17-21. doi: 10.1016/j.amjcard.2021.12.015. Epub 2022 Jan 12. Am J Cardiol. 2022. PMID: 35031111
Patients with cardiomyopathy were predominantly women (78%) and showed the highest incidence of major adverse cardiovascular events at 30 days follow-up (7%; p = 0.012), 1 year (19%; p = 0.004), and mortality at long-term follow-up (27%; p = 0.010) compared with any other …
Patients with cardiomyopathy were predominantly women (78%) and showed the highest incidence of major adverse cardiovascular events at 30 da …
Long-term outcome after deferred revascularization due to negative fractional flow reserve in intermediate coronary lesions.
Weerts J, Pustjens T, Amin E, Ilhan M, Veenstra LF, Theunissen RALJ, Vainer J, Stein M, Ruiters LAW, Gho BCG, Van't Hof AWJ, Rasoul S. Weerts J, et al. Among authors: van t hof awj. Catheter Cardiovasc Interv. 2021 Feb 1;97(2):247-256. doi: 10.1002/ccd.28753. Epub 2020 Jan 30. Catheter Cardiovasc Interv. 2021. PMID: 31999077 Free PMC article.
OBJECTIVES: The aim was to assess long-term outcome after deferring intervention of coronary lesions with a fractional flow reserve (FFR) value of >0.80 in a real-world patient population and then to identify factors associated with deferred target lesion failure (DTLF) …
OBJECTIVES: The aim was to assess long-term outcome after deferring intervention of coronary lesions with a fractional flow reserve ( …
82 results